The question put to the Council was: What are the factors that the Ministry should consider in ranking or prioritizing the timing of drug funding reviews? [...] The Council reports to the Executive Officer of the OPDP and to the Minister of Health. [...] Citizens’ Council Report on Drug Review Prioritization - February 19, 2014 6 Ms McArthur emphasized that the role of the Council in this discussion was to weigh the different criteria that could be used in deciding how the Ministry ranks or prioritizes the reviews of some products over other products, based on the values identified by Council, with the starting point being the Values Framework (se [...] She also asked the Council to assume that the CED has integrity as a review body and that the efficiency of the process of the review not be our focus. [...] The issue the Council is addressing in this session was not about the availability of a drug in Ontario, but rather the availability of the drug to patients who have their prescriptions paid for by OPDP.
health compliance research drugs chemicals medicine pharmaceutical industry quality of life health care evidence-based medicine therapy health system evidence-based pharmaceutical policy healthcare policy health treatment health sciences government health care medical drugs pharmaceutical preventive healthcare pharmaceutical companies therapeutic qaly quality-adjusted life year evidence based qalys pharmaceutical drug pharmacopoeias quality adjusted life years quality adjusted life year